Neurodegeneration Suppliers & Manufacturers

At Sibylla Biotech, we face the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs. Born out of a scientific challenge, the PPI-FIT protocol (Pharmacological Protein Inactivation by Folding ...

Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...

Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...

Iconeus, based in Paris, is renowned for pioneering the functional ultrasound technology specifically designed for imaging cerebrovascular activity. Their flagship product, the Iconeus One, integrates high-sensitivity, high-speed, and ...

Traditional technologies currently utilized for the diagnosis of Alzheimer's and Parkinson's disease are not sensitive enough to perform early detection and need central spinal fluid (CSF) samples from patients, which is invasive and painful. Our ...

Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...

We are committed to developing new areas such as mitochondrial genome sequencing, gene mutation, comparative genomics and epigenetics, and provide highly customized services. Creative Biogene provides a comprehensive range of Separation & Extraction ...

C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...

Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...

MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools. Our first objective is to demonstrate clinical proof-of-concept with our lead compound ...

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...

Alkermes is focused on developing innovative medicines that aim to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated global biopharmaceutical company, we apply our scientific expertise and ...

Neurodigitech (NDT) is dedicated to 1) Neurohistological and neuropathological services of the central nervous system (CNS), 2) Neural staining kits, 3) High-throughput digital microscopic imaging and stereology-based quantitative morphology, and 4) ...

Established in 2007, StressMarq Biosciences is a bioreagents company producing high quality, cutting edge research products for the life sciences and drug discovery/biopharma markets. StressMarq is a market leader in the development and ...

Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI. Programming RNA Therapies Any Gene, Any Genetic Condition. Revolutions in AI, RNA biology and automation ...

Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...

Advanced Brain Monitoring is a neuro-diagnostics device company internationally recognized for its innovative technologies. Our products are used by clinicians, researchers and in clinical trials to interpret brain and physiological function as they ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...

Kurve Therapeutics drug delivery technology is designed to target the most difficult part of the treatment process - getting medication through the blood-brain barrier and into the brain. Kurve Therapeutics has 18 peer-reviewed publications of ...

Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for ...